Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
STAAR Surgical Co STAA
$22.43
β² +7.47%
(+$1.56)
⬆️ Above Yest. High
Open
$22.20
Prev Close
$20.87
Day Range
$21.95 β $22.92
52W Range
$15.59 β $35.87
Market Cap
$1.12B
P/E (TTM)
291.60
Beta
1.26
EPS (TTM)
$0.07
π Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1992-02-24 |
| Shares Out. | 49,790,000 |
| Website | staar.com/ β |
| Phone | 16263037902 |
| Employees | 957 |
| Revenue | $93.5M |
| Gross Profit | $69.7M |
| Net Income | $8.1M |
| Free Cash Flow | -$6.7M |
| Total Assets | $475.2M |
| Total Liabilities | $109.8M |
| Equity | $365.4M |
About STAAR Surgical Co
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
STAAR Surgical Co is a publicly traded company under the ticker symbol STAA on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
18 analysts (2026-09-01)
π° Latest News for STAA
STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know
STAAR Surgical jumps on Stifel upgrade citing China growth potential
Here Are Tuesdayβs Top Wall Street Analyst Research Calls: AutoZone, Baker Hughes, FS KKR Capital, Kroger, Netflix, PepsiCo, Ryder Systems, SpaceX, Warner Bros. Discovery, and More
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
CarMax Posts Upbeat Q2 Earnings, Joins Iovance Biotherapeutics, Perella Weinberg Partners And Other Big Stocks Moving Higher On Tuesday
Robinhood To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $31
